For example, deletion of the gene encoding xCT has been reported to inhibit tumor growth in both pancreatic cancer xenograft models (107) and established tumors in a Kras and p53-driven transgenic mouse model of pancreatic cancer (78). This evidence concerns the gene TP53 and neoplasm.